Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
298
-
Total 13F shares, excl. options
-
52.9M
-
Shares change
-
-2.35M
-
Total reported value, excl. options
-
$3.71B
-
Value change
-
-$146M
-
Put/Call ratio
-
0.67
-
Number of buys
-
165
-
Number of sells
-
-96
-
Price
-
$70.11
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2020
358 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2020.
Editas Medicine, Inc. - Common Stock (EDIT) has 298 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.9M shares
of 82.8M outstanding shares and own 63.91% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (10.1M shares), VANGUARD GROUP INC (5.82M shares), BlackRock Inc. (5.31M shares), Nikko Asset Management Americas, Inc. (4.39M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.39M shares), STATE STREET CORP (2.27M shares), FEDERATED HERMES, INC. (1.72M shares), D. E. Shaw & Co., Inc. (1.41M shares), Capital World Investors (1.4M shares), and CHEVY CHASE TRUST HOLDINGS, INC. (1.2M shares).
This table shows the top 298 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.